
1. Sikiric P, et al. Stable gastric pentadecapeptide BPC-157: healing of GI lesions and tissue protection. *World J Gastroenterol*. 2010;16(24):3103–3110. doi:10.3748/wjg.v16.i24.3103
2. Staresinic M, et al. BPC-157 accelerates healing of tendon and ligament injuries. *J Orthop Res*. 2003;21(5):976–983. doi:10.1016/S0736-0266(03)00046-6
3. Pickart L, Margolina A. GHK-Cu: peptide regulation of gene expression, tissue remodeling, and anti-cancer pathways. *Biomed Res Int*. 2014;2014:151479. doi:10.1155/2014/151479
4. Maquart FX, et al. GHK-Cu stimulates collagen and glycosaminoglycan synthesis in fibroblasts. *FEBS Lett*. 1988;238(2):343–346. doi:10.1016/0014-5793(88)80476-3
5. Goldstein AL, et al. Thymosin β4 and TB-500 in tissue regeneration and angiogenesis. *Ann N Y Acad Sci*. 2010;1194:87–96. doi:10.1111/j.1749-6632.2010.05477.x
6. Malinda KM, et al. Thymosin β4 accelerates wound healing by stimulating angiogenesis and cell migration. *J Invest Dermatol*. 1999;113(3):364–372. doi:10.1046/j.1523-1747.1999.00708.x
7. Star RA, et al. KPV peptide inhibits inflammation via NF-κB modulation in colitis models. *J Pharmacol Exp Ther*. 2002;302(2):953–960. doi:10.1124/jpet.102.033365
8. Rajendran R, et al. Anti-inflammatory tripeptide KPV reduces cytokine activity and intestinal inflammation. *Peptides*. 2003;24(3):397–402. doi:10.1016/S0196-9781(03)00095-1
9. Siméon A, et al. GHK-Cu and tissue remodeling: activation of proteoglycan synthesis. *J Invest Dermatol*. 2000;115(6):962–968. doi:10.1046/j.1523-1747.2000.00164.x
10. Brcic L, et al. Peptide-based regenerative medicine: combined effects of BPC-157, GHK-Cu, TB-500, and KPV. *Curr Pharm Des*. 2018;24(18):2025–2037. doi:10.2174/1381612824666180703111730
2. Staresinic M, et al. BPC-157 accelerates healing of tendon and ligament injuries. *J Orthop Res*. 2003;21(5):976–983. doi:10.1016/S0736-0266(03)00046-6
3. Pickart L, Margolina A. GHK-Cu: peptide regulation of gene expression, tissue remodeling, and anti-cancer pathways. *Biomed Res Int*. 2014;2014:151479. doi:10.1155/2014/151479
4. Maquart FX, et al. GHK-Cu stimulates collagen and glycosaminoglycan synthesis in fibroblasts. *FEBS Lett*. 1988;238(2):343–346. doi:10.1016/0014-5793(88)80476-3
5. Goldstein AL, et al. Thymosin β4 and TB-500 in tissue regeneration and angiogenesis. *Ann N Y Acad Sci*. 2010;1194:87–96. doi:10.1111/j.1749-6632.2010.05477.x
6. Malinda KM, et al. Thymosin β4 accelerates wound healing by stimulating angiogenesis and cell migration. *J Invest Dermatol*. 1999;113(3):364–372. doi:10.1046/j.1523-1747.1999.00708.x
7. Star RA, et al. KPV peptide inhibits inflammation via NF-κB modulation in colitis models. *J Pharmacol Exp Ther*. 2002;302(2):953–960. doi:10.1124/jpet.102.033365
8. Rajendran R, et al. Anti-inflammatory tripeptide KPV reduces cytokine activity and intestinal inflammation. *Peptides*. 2003;24(3):397–402. doi:10.1016/S0196-9781(03)00095-1
9. Siméon A, et al. GHK-Cu and tissue remodeling: activation of proteoglycan synthesis. *J Invest Dermatol*. 2000;115(6):962–968. doi:10.1046/j.1523-1747.2000.00164.x
10. Brcic L, et al. Peptide-based regenerative medicine: combined effects of BPC-157, GHK-Cu, TB-500, and KPV. *Curr Pharm Des*. 2018;24(18):2025–2037. doi:10.2174/1381612824666180703111730